LONGEVERON INC. (LGVN)
Longeveron Announces 1-for-10 Reverse Stock Split
Longeveron Announces 1-for-10 Reverse Stock Split
Xanadu Announces Technological Roadmap Presentation
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026
Homes.com Shares Most Expensive Home Sales Across Major U.S. Markets in July